Dr Danijela Kocic is the Scientific Head of Clinical Pharmacology and Toxicology for SydPath at the St. Vincent’s Hospital in Sydney, Australia. She manages the analysis of Therapeutic Drug Monitoring results to clinicians, patients and other clients requesting rigorous analytical services with a view to optimising patient outcomes in a variety of complex clinical settingsDr Kocic is an active member of TDM Matters Multi-Disciplinary Team Service at St Vincent’s Hospital and recently was appointed as a Conjoint Lecturer at St Vincent’s Clinical School, University of NSW. Dr Kocic is a leading committee member of the NSW Health Pathology Clinical Mass Spectrometry Forum.
Dr Kocic commenced her scientific career with Novartis Pharmaceuticals as a Research Scientist. Following the completion of her PhD, she moved to the Drug Toxicology Unit of the NSW Forensic and Analytical Scientific Service as a Senior Scientist in Charge of Research & Development and Innovation, continuing to develop high-throughput, robust methods for drug detection and confirmation.
Her research interests are the improvement of the sample throughput of standard LC-MS/MS equipment using Active Flow Technology, TDM and personalised medicine.